AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment

benzinga.com/news/contracts/25/07/46249640/astrazeneca-in-15b-talks-for-drug-that-could-upend-lung-cancer-treatment

In a high-stakes maneuver that could reshape the oncology landscape, AstraZeneca Plc (NASDAQ:AZN) is reportedly in talks with Summit Therapeutics Inc. (NASDAQ:SMMT) about a partnership worth up to $15 billion.
What Does This Mean?
The deal would give AstraZeneca the rights to a lung…

This story appeared on benzinga.com, 2025-07-03 15:56:10.
The Entire Business World on a Single Page. Free to Use →